Use of hydroxychloroquine and chloroquine in COVID-19: How good is the quality of randomized controlled trials?

OBJECTIVES: We critically evaluated the quality of evidence and quality of harm reporting in clinical trials that evaluated the effectiveness of hydroxychloroquine (HCQ) or chloroquine (CQ) for the treatment of coronavirus disease 2019 (COVID-19). STUDY DESIGN AND SETTING: Scientific databases were...

Descripción completa

Detalles Bibliográficos
Autores principales: Mazhar, Faizan, Hadi, Muhammad Abdul, Kow, Chia Siang, Marran, Albaraa Mohammed N., Merchant, Hamid A., Hasan, Syed Shahzad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases. 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7524513/
https://www.ncbi.nlm.nih.gov/pubmed/33007453
http://dx.doi.org/10.1016/j.ijid.2020.09.1470

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7524513/
https://www.ncbi.nlm.nih.gov/pubmed/33007453
http://dx.doi.org/10.1016/j.ijid.2020.09.1470

Ejemplares similares